Cocktail Reception & Program
Immunotherapy – you have heard of it, but what exactly is it and how does it work?
Hear from a pioneer in the immunorevolution, Dr. Padmanee Sharma, as she answers these questions and explains the benefits of immunotherapy approaches for cancer treatments and what the future holds.
Guest Speaker Bio
Padmanee Sharma, M.D., Ph.D., scientific director of the Immunotherapy Platform, professor of Genitourinary Medical Oncology, and professor of Immunology at The University of Texas MD Anderson Cancer Center
Dr. Sharma is a nationally and internationally renowned physician scientist whose work focuses on investigating mechanisms and pathways within the immune system that facilitate tumor rejection or elicit resistance in response to immune checkpoint therapy. She is a trained medical oncologist and immunologist and is the T.C. and Jeanette D. Hsu Endowed Chair in Cell Biology at MD Anderson. In 2004, she designed and conducted the first pre-surgical trial with immune checkpoint therapy (anti-CTLA-4), which allowed her to study the impact of immune checkpoint therapy on human tumors, and subsequently identified a novel target pathway for cancer immunotherapy strategies. Dr. Sharma continues to design novel pre-surgical trials to evaluate human immune responses to different immunotherapies and is the principal investigator on multiple immunotherapy clinical trials.
Dr. Sharma is a graduate of Pennsylvania State University College of Medicine, where she also obtained her doctoral degree in immunology. She completed postgraduate training at Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. Dr. Sharma is a member of the American Society for Clinical Investigation and received the Emil Frei III Award for Excellence in Translational Research and the Coley Award for Distinguished Research for Tumor Immunology.
Learn more about Wistar's Women & Science Program.
The Wistar Institute
3601 Spruce Street
Philadelphia PA 19104